Industry Experts Announced for BIO’s Investor Conference
- Contact: Carrie Housman, BIO, (202) 962-9200
Ashley Myler, SheaHedges Group, (703) 287-7823
Related Content
- Industry Experts on Drug Development and Genetic Testing Announced for BIO’s CEO & Investor Conference
- MEDIA ADVISORY --- BIO CEO & Investor Conference 2002: Highlight of Events for Friday, February 22, 2002
- Three New Media Briefings Added To BIO's CEO & Investor Conference
- MEDIA ADVISORY --- BIO CEO & Investor Conference 2002: Highlights for Wednesday, February 20, 2002
Washington, D.C. (February 14, 2002) - The Biotechnology Industry Organization (BIO) today announced the names of industry leaders who will participate in the opening and closing plenary sessions of the fourth annual CEO & Investor Conference, Feb. 20-22 at the Waldorf-Astoria Hotel in New York.
OPENING PLENARY SESSION
| WHAT: | “Building Shareholder Value Through Merger & acquisition” |
| WHEN: | Wednesday, Feb. 20, 8:00 - 9:20 a.m. |
| WHO: | Panelists David Mott, CEO of MedImmune, Inc. C. Boyd Clarke, CEO of Aviron Kevin Starr, COO of Millennium Pharmaceuticals, Inc. Vaughn Kailian, vice chairman of Millennium Pharmaceuticals, Inc., and former CEO of COR Therapeutics, Inc. Joshua Boger, CEO of Vertex Pharmaceuticals, Inc. Stuart Collinson, former CEO of Aurora Biosciences Corporation Moderators Tracy Lefteroff, global life sciences director for PriceWaterhouseCoopers, LLP Eric Roberts, managing director of Lehman Brothers |
| WHERE: | Waldorf-Astoria Hotel, Grand Ballroom |
CLOSING PLENARY SESSION
| WHAT: | “Managing through Biotech’s Binary Events” |
| WHEN: | Friday, Feb. 22, 12:00 - 1:30 p.m. |
| WHO: | Analysts and Fund Managers Denis Purcell, senior managing partner of Perseus/Soros BioPharmaceutical Fund LLC Steve Delco, analyst for Fortis Bank Mary Ann Gray, health-care analyst for the Federated Kaufmann Fund Bill Slattery, partner and biotechnology analyst for Deerfield Partners CEO Panelists Vaughn Kailian, vice chairman of Millennium Pharmaceuticals, Inc., and former CEO of COR Therapeutics, Inc. Raymond Warrell, MD, CEO of Genta, Inc. Richard Pops, CEO of Alkermes, Inc. Moderator Vivian Lee, managing director of Roberts Mitani Aqua Partners |
| WHERE: | Waldorf-Astoria Hotel, Grand Ballroom |
For more information on the CEO & Investor Conference 2002, please visit www.investinbio.com. Press registration is complimentary for credentialed members of the news media. Advance press registration closes on Feb. 14. Press releases, conference updates and registration information are posted in the “Media” section of the conference Web site. Contact Carrie Housman at BIO (202-962-9200) with any questions.
BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products. For more information, please visit www.bio.org.
# # #
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.
